Skip to main content
. 2017 Sep 8;9(25):1043–1053. doi: 10.4254/wjh.v9.i25.1043

Table 3.

Risk of hepatitis B virus reactivation according to different immunosuppressive drug classes (adapted from[21])

Risk Drug class
High (> 10%) B-cell depleting agents
Anthracycline
Corticosteroids high dose
Moderate (1%-10%) TNFα inhibitors
Cytokine and integrin inhibitors
Tyrosine kinase inhibitors
Corticosteroids moderate dose
Low (< 1%) Corticosteroids low dose
Traditional immunosuppression (e.g., azathioprine or methotrexate)